Research Topics
| A N ViswanathanSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Night shift work and the risk of endometrial cancerAkila N Viswanathan
Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
Cancer Res 67:10618-22. 2007..Our results add to growing literature that suggests women who work at night may benefit from cancer prevention strategies...
Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancerAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
Cancer Res 68:2507-13. 2008..However, risk was significantly lower for current aspirin users who were obese or who were postmenopausal and had never used PMHs; these subgroup findings require further confirmation...
A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapyAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA Electronic address
Brachytherapy 12:240-7. 2013..To present outcome and toxicity results of the first real-time intraoperative MRI-guided interstitial approach to gynecologic cancer...- The importance of chemotherapy and radiation in uterine papillary serous carcinomaAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Gynecol Oncol 123:542-7. 2011..To identify prognostic and predictive factors of overall survival (OS), relapse-free survival (RFS) and toxicity for patients with uterine papillary serous carcinoma (UPSC)... - Advances in the use of radiation for gynecologic cancersAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
Hematol Oncol Clin North Am 26:157-68. 2012.... - The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128Akila N Viswanathan
Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Int J Gynecol Cancer 22:123-31. 2012..The objective of the study was to determine the impact of brachytherapy implant quality on outcome among cervical cancer patients treated on Radiation Therapy Oncology Group prospective trials 0116 and 0128... - Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancerAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
Radiographics 28:289-307. 2008 - Circulating melatonin and the risk of breast and endometrial cancer in womenAkila N Viswanathan
Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Cancer Lett 281:1-7. 2009..Additional studies are needed to delineate further the potential of melatonin in cancer prevention... - Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy SocietyAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 76:104-9. 2010..To determine current practice patterns with regard to three-dimensional (3D) imaging for gynecologic brachytherapy among American Brachytherapy Society (ABS) members... - Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancerAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Gynecol Cancer 19:1402-6. 2009..To evaluate factors affecting survival and toxicity in patients with stage IIIB cervical cancer treated with external-beam radiotherapy and low-dose-rate brachytherapy... - Radiation dose-volume effects of the urinary bladderAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 76:S116-22. 2010..The data on partial-organ/nonuniform irradiation are suspect because the bladder motion is not accounted for, and many studies lack long enough follow-up data. Future studies are needed... - International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)Akila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 82:250-5. 2012.... - The Frank Ellis memorial lecture: the use of three-dimensional imaging in gynaecological radiation therapyA N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, 75 Francis Street L2, Boston, MA 02115, USA
Clin Oncol (R Coll Radiol) 20:1-5. 2008..This lecture will focus on novel advances in three-dimensional image-guided radiation therapy for cervical cancer, with the ultimate goal of improving outcomes for our patients... - Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancerAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 66:91-9. 2006..To evaluate the feasibility and to describe the acute toxicity of a real-time intraoperative magnetic resonance (MR)-image guided interstitial approach to treating vaginal recurrence of endometrial cancer... - Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contoursAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA, USA
Int J Radiat Oncol Biol Phys 68:491-8. 2007..To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy... - Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapyLarissa J Lee
Harvard Radiation Oncology Program, Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, 75 Francis Street, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 75:803-9. 2009..To compare high dose rate (HDR) point B to pelvic lymph node dose using three-dimensional-planned brachytherapy for cervical cancer... - Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapyAlexandra J Stewart
Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
Int J Radiat Oncol Biol Phys 72:843-8. 2008..To investigate the effect of bladder filling on dosimetry and to determine the best bladder dosimetric parameter for vaginal cuff brachytherapy... - Sigmoid dose using 3D imaging in cervical-cancer brachytherapyCaroline L Holloway
Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, MA, USA
Radiother Oncol 93:307-10. 2009..To evaluate the proximity, variance, predictors of dose, and complications to the sigmoid in cervical-cancer brachytherapy using 3D planning... - Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrenceAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA
Gynecol Oncol 93:27-33. 2004..Brain metastases were seen only in patients who also had lung metastases, suggesting that prophylactic cranial irradiation would be of little benefit... - Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancerAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 65:1501-7. 2006..To examine the relationship between margin status and local recurrence (LR) or any recurrence after radical hysterectomy (RH) in women treated with or without radiotherapy (RT) for Stage IB cervical carcinoma... - Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancerAlexandra J Stewart
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 107:908-15. 2006.... - Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapyAkila N Viswanathan
Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 58:1208-14. 2004..To analyze the sites of relapse, relapse-free survival, and overall survival in children with Group III rhabdomyosarcoma treated with or without radiotherapy (RT)... - Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulvaRaymond H Mak
Harvard Radiation Oncology Program, Boston, MA, USA
Gynecol Oncol 120:101-7. 2011..To compare outcomes in patients with squamous cell carcinoma (SCC) of the vulva treated with radiation (RT) and concurrent weekly platinum-based or every-3-4-week regimens containing 5-fluorouracil (5-FU)... - Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapyCaroline L Holloway
Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, 75 Francis Street L2, Boston, Massachusetts, MA 02115, USA
Gynecol Oncol 104:253-6. 2007..Vulvar synovial cell sarcomas are rare, with only four previously published cases in the literature. Traditionally, the primary management for these tumors has been surgery alone... - Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survivalMartin C Chang
Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Int J Gynecol Pathol 29:88-92. 2010..Extensive, recurring AIS is a rare variant that may be unique for its risk of coincident ovarian involvement. However, ovarian spread, albeit rare, does not invariably result in an adverse outcome... - Smoking and the risk of endometrial cancer: results from the Nurses' Health StudyAkila N Viswanathan
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Int J Cancer 114:996-1001. 2005..The findings provide insight into disease etiology and suggest that the influence of smoking on endometrial cancer risk occurs even in early adulthood, is long-lasting, and may not be attributed solely to short-term hormonal modulation... - Computed tomography-based radiation therapy of ovarian remnants for symptomatic persistent endometriosisKarl E Haglund
Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Obstet Gynecol 111:579-83. 2008..Endometriosis, a major cause of pelvic pain in women, is driven by estrogen. Ovarian remnant irradiation may alleviate pelvic pain by eliminating estrogen production in appropriately selected women with endometriosis...